Skip Navigation Links.
American Journal of Medical and Biological Research. 2013, 1(1), 1-5
DOI: 10.12691/AJMBR-1-1-1
Original Research

Prevalence and Polymorphism in Interferon-γ Gene (CA) Repeats with Different Stages of Endometriosis

Venkanna Bhanothu1, , Roya Rozati2 and Jane Theophilus1

1Department of Medicine and Laboratory of Kidney Pathology, Charles Nicolle Hospital, Tunis, Tunisia

2Ministry of Public Health, Tunis, Tunisia

Pub. Date: February 15, 2013
Full Text PDF

Cite this paper

Venkanna Bhanothu, Roya Rozati and Jane Theophilus. Prevalence and Polymorphism in Interferon-γ Gene (CA) Repeats with Different Stages of Endometriosis. American Journal of Medical and Biological Research. 2013; 1(1):1-5. doi: 10.12691/AJMBR-1-1-1

Abstract

Background: Endometriosis is a female physical disorder that happens when cells from the lining of the womb (uterus) grow in other areas of the body i.e., outside of uterine cavity and leads to infertility. It represents a major personal and public health concern. The aim of the study was to investigate the prevalence and interferon-gamma gene CA-repeats polymorphism in patients with different stages of endometriosis.Methodology/Principal Findings: It is a case control prevalence study carried out in gynecology research centre. The mutational analysis of Interferon-γ gene CA repeats were tested for association in 356 affected women with different stages of disease and 372 women with no evidence of disease. The prevalence of endometriosis was accounted in 44.95% of infertile women. All the women were of South Indian origin and ascertained from the same infertility clinic. The broad IFN-gamma genotype and allele frequencies in all patients with different stages of endometriosis varied significantly from that in the control women (χ2 = 8.2690, 4 df, P =0.0822). The disparity in distribution was due to an increase in the a13 (114 bp) allele in the patients with endometriosis (χ2 =13.2394, p= 0.00027, OR=1.6656, 95.0% CI=1.263-2.1953). Conclusions/Significance: Significant difference was experiential in universal allele frequencies between the control women and specifically, women with endometriosis staging were tilted in the direction of minimal (39.04%) and mild disease (33.98%). Therefore, we conclude that interferon-gamma CA-repeat polymorphism may influence the likelihood of a woman developing different stages of endometriosis irrespective of its incidence.

Keywords

Different stages of endometriosis, Prevalence, Interferon-γ gene polymorphism

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Wenzl R, Kiesel L, Huber JC, Wieser F. Endometriosis: a genetic disease. Drugs Today (Barc) 2003; 39:961-972.
 
[2]  Halis G, Arici A. Endometriosis and inflammation in infertility. Ann N Y Acad Sci 2004; 1034:300-315.
 
[3]  Bischoff F, Simpson JL. Genetic basis of endometriosis. Ann NY Acad Sci 2004; 1034:284-299.
 
[4]  Vigano P, Somigliana E, Vignali M, Busacca M, Blasio AM. Genetics of endometriosis: current status and prospects. Front Biosci 2007; 12: 3247-3255.
 
[5]  Matorras R, Rodriguez F, Pijoan JI, Etxanojauregui A, Neyro JL, Elorriaga MA, Rodriguez-Escudero FJ. Women who are not exposed to spermatozoa and infertile women have similar rates of stage I endometriosis. Fertil Steril 2001; 76:923-928..
 
[6]  Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 2004;18:177-200.
 
[7]  Varma R, Rollason T, Gupta JK, Maher ER. Endometriosis and the neoplastic process. Reproduction 2004; 127:293-304.
 
[8]  Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996; 87:55-8.
 
[9]  Schoenborn JR, Wilson CB. "Regulation of interferon-gamma during innate and adaptive immune responses". Adv. Immunol. 2007; 96: 41-101
 
[10]  Gray PW, Goeddel DV. "Structure of the human immune interferon gene". Nature. August 1982; 298 (5877): 859-63.
 
[11]  Naylor SL, Sakaguchi AY, Shows TB, Law ML, Goeddel DV, Gray PW. "Human immune interferon gene is located on chromosome 12". J. Exp. Med. March 1983; 157 (3): 1020-7
 
[12]  Iwabe T, Harada T, Tsudo T, Nagano Y, Yoshida S, Tanikawa M, Terakawa N. Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab 2000; 85: 824-9.
 
[13]  Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001; 75:1-10.
 
[14]  Podgaec S, Abrao MS, Dias JA Jr, Rizzo LV, de Oliveira RM, Baracat EC Endometriosis: an inflammatory disease with a Th2 immune response component. Hum Reprod 2007; 22 (5):1373-1379
 
[15]  Hong-Nerng Ho, Ming-Yih Wu, Kuang-Han Chao, Chin-Der Chen, Shee-Uan Chen, Hsin-Fu Chen, Yu-Shih Yang. Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis. Am J Obstet Gynecol 1996; 175: 1236-1241.
 
[16]  Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR. Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 1994; 32: 180-183.
 
[17]  Hsu CC, Yang BC, Wu MH, Huang KE. Enhanced interleukin- 4 expression in patients with endometriosis. Fertil Steril 1997; 67:1059-64.
 
[18]  Miyake K, Nakashima H, Akahoshi M, Inoue Y, Nagano S, Tanaka Y, et al. Genetically determined interferon-gamma influences the histological phenotype of lupus nephritis. Rheumatology 2002; 41: 518-524.
 
[19]  Ruiz-Linares A Dinucleotide repeat polymorphism in the interferon gamma (IFN-GAMMA) gene. Hum Mol Genet Sept. 1993; 2 (9): 1508.
 
[20]  Kitawaki J, Koshiba H, Kitaoka Y, Teramoto M, Hasegawa G, Nakamura N, Yoshikawa T, Ohta M, Obayashi H and Honjo H. Interferon-gamma gene dinucleotide (CA) repeat and interleukin-4 promoter region (-590C/T) polymorphisms in Japanese patients with endometriosis. Hum Reprod 2004; 19:1765-1769
 
[21]  Kim J, Choi Y, Hwang S, Yoon S, Lee G, Chae S, Hwang K, Moon S. Association of the interferon-γ gene (CA)n repeat polymorphism with endometriosis. BJOG 2011; 118:1061-1066.
 
[22]  Rozati R, Vanaja MC, Nasaruddin K Genetic contribution of the interferon gamma dinucleotide-repeat polymorphism in South Indian women with endometriosis. J Obstet Gynaecol Res. 2010; 36(4):825-31.
 
[23]  rASRM (1997) Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril 1996; 67: 817-821
 
[24]  Miller SA, Dykes DD and Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
 
[25]  Uitenbroek, Daan G, Binomial. SISA. 1997. http://www.quantitativeskills.com/sisa/distributions/binomial.htm. (1 Jan. 2004).
 
[26]  Giudice LC, Tazuke SI, Swiersz L. Status of current research on endometriosis. J Reprod Med 1998; 43(Suppl 3):252-262.
 
[27]  Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Economic burden of endometriosis. 2006; 86:1561-1572.
 
[28]  Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann N Y Acad Sci 2008; 1127: 92-100.
 
[29]  Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 2002; 17:1415-1423. [PubMed: 12042253]
 
[30]  Strdthy, J.H.. Molgaard, C.A., Coulam, C.B. and Melton, L.J. Endometriosis and infertility: a laparoscopic study of' endometriosis among fertile and infertile women. Fertil. Steril.,1982; 38, 667-672.
 
[31]  Donnez J, Squifflet J. Laparoscopic excision of deep endometriosis. Obstet Gynecol Clin North Am 2004; 31:567-580.
 
[32]  Olive DL, Lindheim SR, Pritts EA. Endometriosis and infertility: what do we do for each stage? Curr Womens Health Rep 2003; 3: 389-394.
 
[33]  Fedele L, Bianchi S, Di Nola G, Candiani M, Busacca M, Vignali M. The recurrence of endometriosis. Ann N Y Acad Sci 1994; 734:358-364
 
[34]  Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest. 2006; 62 (3): 139-147.
 
[35]  Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I. Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod. 2005; 11(1): 29-34.
 
[36]  Krzysztof Szyllo, Henryk Tchorzewski, Malgorzata Banasik, Ewa Glowacka, Przemyslaw Lewkowicz, Anna Kamer-Bartosinska. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. Mediators of Inflammation. June 2003; 12(3): 131-138
 
[37]  Hornung D, Klingel K, Dohrn K, Kandolf R, Wallwiener D, Taylor RN. Regulated on activation, normal T-cell-expressed and secreted mRNA expression in normal endometrium and endometriotic implants: assessment of autocrine/paracrine regulation by in situ hybridization. Am J Pathol 2001; 158: 1949 -1954.
 
[38]  Belardelli F, Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 2002; 23: 201-208.
 
[39]  Gajbhiye R, Suryawanshi A, Khan S, Meherji P, Warty N, Raut V, Chehna N, Khole V. Multiple endometrial antigens are targeted in autoimmune endometriosis. Reprod Biomed Online 2008; 16: 817-24.